September 30, 2024

C2N Diagnostics Secures $15M Investment from GHR Foundation for Advanced Alzheimer’s Disease Testing

C2N Diagnostics, a leader in developing Alzheimer’s disease-specific fluid biomarker tests, has announced a $15 million program-related investment from GHR Foundation to enhance…

Biotech /

September 26, 2024

858 Therapeutics Raises $50 Million in Series B Funding to Advance Cancer Therapeutics

858 Therapeutics has secured $50 million in a Series B funding round led by Avidity Partners, with participation from Insight Partners, Mirae Asset…

Biotech /

September 26, 2024

Mediwhale Raises $12 Million Series A2 Funding to Lead in Cardiovascular and Metabolic Disease Management

Mediwhale, an AI-powered health diagnostics company, has raised $12 million in Series A2 funding to drive its global expansion in cardiovascular and metabolic…

Biotech / Healthcare /

September 25, 2024

Helaina Raises $45 Million in Series B to Advance Human Bioactive Proteins Commercialization

Helaina, a biotechnology company pioneering human-equivalent bioactive proteins, has raised $45 million in Series B funding, bringing its total equity funding to $83…

Biotech /

September 24, 2024

Bluebird bio Layoffs Hit Nearly 100 Jobs as Company Struggles to Stay Afloat

Bluebird bio, a pioneer in gene therapy, is undergoing a major restructuring, cutting 25% of its workforce as it battles to maintain operations….

Biotech /

September 23, 2024

Streamlining Medical Billing with Automation

Medical doctors and practitioners are focused on saving lives, healing the sick, and promoting healthier lifestyles. It is often considered a calling and…

Biotech /

September 23, 2024

Vicebio Raises $100 Million in Series B Financing to Advance Novel Respiratory Vaccines

Featured

Vicebio, a biopharmaceutical company focused on developing next-generation vaccines for life-threatening respiratory viral infections, announced the completion of a $100 million Series B…

Biotech /

September 23, 2024

Lifespan Layoffs hit 20% of Executives as CEO Streamlines Operations

Lifespan, Rhode Island’s largest hospital group, has laid off 20% of its executives as part of a strategic restructure aimed at streamlining operations…

Biotech / Hospitality /

September 11, 2024

PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs

Featured

PhoreMost, a UK-based biopharmaceutical firm, has raised an additional $12 million in its Series B funding round, bringing the total to over $50…

Biotech /

September 11, 2024

Solasta Bio Secures £10.7m to Advance Eco-Friendly Insecticide

Solasta Bio Raises £10.7m for Nature-Based Insecticide Development…

Biotech /

Get Silicon Valley Top 1000 Contacts List

September 30, 2024

C2N Diagnostics Secures $15M Investment from GHR Foundation for Advanced Alzheimer’s Disease Testing

September 26, 2024

858 Therapeutics Raises $50 Million in Series B Funding to Advance Cancer Therapeutics

September 26, 2024

Mediwhale Raises $12 Million Series A2 Funding to Lead in Cardiovascular and Metabolic Disease Management

September 25, 2024

Helaina Raises $45 Million in Series B to Advance Human Bioactive Proteins Commercialization

September 24, 2024

Bluebird bio Layoffs Hit Nearly 100 Jobs as Company Struggles to Stay Afloat

September 23, 2024

Streamlining Medical Billing with Automation

September 23, 2024

Vicebio Raises $100 Million in Series B Financing to Advance Novel Respiratory Vaccines

September 23, 2024

Lifespan Layoffs hit 20% of Executives as CEO Streamlines Operations

September 11, 2024

PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs

September 11, 2024

Solasta Bio Secures £10.7m to Advance Eco-Friendly Insecticide

Follow Silicon Valley Journals

Awarded by

Fundings

Quick links

Company